SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

Quidel Corporation QDEL recently announced that it will make its non-prescription QuickVue At-Home OTC COVID-19 Test available to consumers from the next week. The test will be available at more than ...

The COVID-19 pandemic has enabled consumers to perform rapid self-tests in the comfort of their homes, a convenient option that test makers like Abbott Laboratories, Becton Dickinson and Quidel are ...

SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

After a blockbuster two years bolstered by sales of its multiple COVID-19 diagnostics, Quidel is looking for a way to reinvest that windfall back into the business—and seems to have found it in the ...

Quidel fell the most because its COVID-19 test, the Sofia SARS Antigen FIA, is in the same class as Abbott's BinaxNOW COVID-19 Ag Card test. Both are so-called antigen tests that detect the ...

Looking at a longer time period, QDEL stock is up 122% from levels of under $50 seen toward the end of 2018. The rise in the stock price over the last two years or so can be attributed to favorable ...

Quidel is recalling its Lyra COVID-19 test because of a “significant” risk of false negative results in people infected with high amounts of the virus, the FDA said July 7. The test, which was granted ...

Summer is time for camp—but it's also prime season for Lyme disease. That's the reminder from diagnostic maker Quidel, which has launched an awareness campaign highlighting the rise and risk of the ...

Credit: Medical Images. This recall has been classified as a Class I recall. Quidel Cardiovascular Inc is recalling the Quidel Triage Cardiac Panel because of the potential risk for false negative ...